✦ LIBER ✦

A Phase II Study of Cetuximab/Irinotecan in Patients with Heavily Pretreated Metastatic Colorectal Cancer: Predictive Value of Early Specific Toxicities

✍ Scribed by Teresa Gamucci; Fabrizio Nelli; Giovanni Cianci; Giulia Grassi; Luca Moscetti; Isabella Sperduti; Massimo Zeuli; Enrico Cortesi; Giuliana D'Auria; Camillo Francesco Pollera

Book ID: 119935155
Publisher: CIG Media Group, LP.
Year: 2008
Tongue: English
Weight: 114 KB
Volume: 7
Category: Article
ISSN: 1533-0028
DOI: 10.3816/ccc.2008.n.035

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter phase II study of G17DT im

A multicenter phase II study of G17DT immunogen plus irinotecan in pretreated metastatic colorectal cancer progressing on irinotecan

✍ Caio Max Rocha-Lima… 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 249 KB

Phase II study of irinotecan plus capeci

Phase II study of irinotecan plus capecitabine in anthracycline- and taxane- pretreated patients with metastatic breast cancer

✍ Keun Seok Lee, In Hae Park, Byung-Ho Nam, Jungsil Ro 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 186 KB

A phase II study of capecitabine, irinot

A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancer

✍ Daniel J. Renouf; Stephen Welch; Malcolm J. Moore; Monika K. Krzyzanowska; Jenni 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 294 KB

Phase II Study of Weekly Albumin-Bound P

Phase II Study of Weekly Albumin-Bound Paclitaxel for Patients with Metastatic Breast Cancer Heavily Pretreated with Taxanes

✍ Joanne L. Blum; Michael A. Savin; Gerald Edelman; John E. Pippen; Nicholas J. Ro 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 113 KB

A phase II study of paclitaxel in heavil

A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer

✍ Smit, EF; Fokkema, E; Biesma, B; Groen, HJM; Snoek, W; Postmus, PE 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 852 KB

A phase II study of irinotecan in combin

A phase II study of irinotecan in combination with doxifluridine, an intermediate form of capecitabine, in patients with metastatic colorectal cancer

✍ Takeshi Kato; Hideyuki Mishima; Masakazu Ikenaga; Kouhei Murata; Hideyuki Ishida 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 259 KB